ACM
NAMSW icon

ADAR1 Capital Management’s NewAmsterdam Pharma Warrant NAMSW Stock Holding History

ADAR1 Capital Management’s Portfolio NAMSW Stock Details NAMSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-82,857
Closed -$259K – 280
2023
Q4 		$259K Buy
+82,857
New +$162K 0.09% 76

Other funds holding NAMSW

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
VI
Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return

ADAR1 Capital Management's NAMSW Position: Q1 2024 in Review

ADAR1 Capital Management sold out of NewAmsterdam Pharma Warrant (NAMSW) in Q1 2024, closing a stake of 82,857 shares — an estimated $259K sold.

ADAR1 Capital Management first reported a position in NAMSW in Q4 2023 and held it in 1 quarter. The position peaked at $259K in Q4 2023. 11 funds tracked by Wall St. Rank hold NAMSW as of Q1 2024.

  • ADAR1 Capital Management reported no remaining NewAmsterdam Pharma Warrant position as of Q1 2024 after selling out during the quarter.
  • ADAR1 Capital Management sold 82,857 NewAmsterdam Pharma Warrant shares in Q1 2024, an estimated $259K.
  • ADAR1 Capital Management first reported a position in NewAmsterdam Pharma Warrant in Q4 2023 and held it in 1 quarter.
  • ADAR1 Capital Management's NewAmsterdam Pharma Warrant position peaked at $259K in Q4 2023.
  • 11 funds tracked by Wall St. Rank held NewAmsterdam Pharma Warrant as of Q1 2024.

Based on ADAR1 Capital Management's 13F filing for Q1 2024, filed 15 May 2024.